Applied Therapeutics
New York
About Applied Therapeutics
Applied Therapeutics operates as a biotechnology company. The company focuses on developing transformative drugs in areas of high unmet medical need -fatal and debilitating diseases for which no therapies are approved. The company is developing a pipeline of novel product candidates against previously validated and well-known molecular targets. It uses technological advances and abbreviated regulatory pathways, wherever possible, to design drugs for indications of significant unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $419.1M
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2024)
- Ticker: nasdaq:APLT
- Website: appliedtherapeutics.com
- Phone: +1 212 220 9319
Industries & Categories
Biotechnology, Health Care, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/applied-therapeutics-68376 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.